Reply to: "Selection of MRI contrast agent and diagnostic criteria for HCC to maximize the advantages of contrast agents". Paisant A, Vilgrain V, Aube C. J Hepatol 2020;73:716-717.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paisant A, Vilgrain V, Aube C. Reply to: "Selection of MRI contrast agent and diagnostic criteria for HCC to maximize the advantages of contrast agents". J Hepatol 2020;73:716-717.
PMID: 32546402